Matches in Nanopublications for { ?s ?p "ICI (ERalpha inhibitor fulvestrant) activates NF-kappaB and AP-1 activities in MCF-7 cells and ER alpha reduces NF-kappaB, AP-1 activities as well as Fra2 (Fosl2), c-jun, RelB {protein} levels in MDA-MB-231 breast cancer cells" ?g. }
Showing items 1 to 7 of
7
with 100 items per page.
- _3 value "ICI (ERalpha inhibitor fulvestrant) activates NF-kappaB and AP-1 activities in MCF-7 cells and ER alpha reduces NF-kappaB, AP-1 activities as well as Fra2 (Fosl2), c-jun, RelB {protein} levels in MDA-MB-231 breast cancer cells" provenance.
- _3 value "ICI (ERalpha inhibitor fulvestrant) activates NF-kappaB and AP-1 activities in MCF-7 cells and ER alpha reduces NF-kappaB, AP-1 activities as well as Fra2 (Fosl2), c-jun, RelB {protein} levels in MDA-MB-231 breast cancer cells" provenance.
- _5 value "ICI (ERalpha inhibitor fulvestrant) activates NF-kappaB and AP-1 activities in MCF-7 cells and ER alpha reduces NF-kappaB, AP-1 activities as well as Fra2 (Fosl2), c-jun, RelB {protein} levels in MDA-MB-231 breast cancer cells" provenance.
- _5 value "ICI (ERalpha inhibitor fulvestrant) activates NF-kappaB and AP-1 activities in MCF-7 cells and ER alpha reduces NF-kappaB, AP-1 activities as well as Fra2 (Fosl2), c-jun, RelB {protein} levels in MDA-MB-231 breast cancer cells" provenance.
- _3 value "ICI (ERalpha inhibitor fulvestrant) activates NF-kappaB and AP-1 activities in MCF-7 cells and ER alpha reduces NF-kappaB, AP-1 activities as well as Fra2 (Fosl2), c-jun, RelB {protein} levels in MDA-MB-231 breast cancer cells" provenance.
- _3 value "ICI (ERalpha inhibitor fulvestrant) activates NF-kappaB and AP-1 activities in MCF-7 cells and ER alpha reduces NF-kappaB, AP-1 activities as well as Fra2 (Fosl2), c-jun, RelB {protein} levels in MDA-MB-231 breast cancer cells" provenance.
- _5 value "ICI (ERalpha inhibitor fulvestrant) activates NF-kappaB and AP-1 activities in MCF-7 cells and ER alpha reduces NF-kappaB, AP-1 activities as well as Fra2 (Fosl2), c-jun, RelB {protein} levels in MDA-MB-231 breast cancer cells" provenance.